Yes, understanding factors like insulin resistance, inflammation, cortisol imbalance, nutrient deficiencies, gut health, and metabolic dysfunction can help improve long-term outcomes with peptide therapies
Pfizer recently announced it decided to discontinue clinical trials of its oral GLP-1 medication for weight loss, called danuglipron, after a study participant experienced a liver injury that was potentially linked to the experimental drug
This includes your medication, supplies, and access to our support teamall with no hidden fees or surprise costs
The adhesive patches being sold online today are completely different, and companies that use terms like microneedle to market them are misleading consumers
J Clin Endocrinol Metab (2020) 105(8):e27106